OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
Irene García-García, Enrique Seco-Meseguer, Pilar Ruíz-Seco, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1139-1139
Open Access | Times Cited: 11
Irene García-García, Enrique Seco-Meseguer, Pilar Ruíz-Seco, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1139-1139
Open Access | Times Cited: 11
Showing 11 citing articles:
Prophylaxis against covid-19: living systematic review and network meta-analysis
Jessica Bartoszko, Reed Siemieniuk, Elena Kum, et al.
BMJ (2021), pp. n949-n949
Open Access | Times Cited: 103
Jessica Bartoszko, Reed Siemieniuk, Elena Kum, et al.
BMJ (2021), pp. n949-n949
Open Access | Times Cited: 103
Assessing the antiviral potential of melatonin: A comprehensive systematic review
Tasneem Alomari, Haneen Al‐Abdallat, Rawan Hamamreh, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 6
Tasneem Alomari, Haneen Al‐Abdallat, Rawan Hamamreh, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 6
Melatonin as a complementary and prophylactic agent against COVID‐19 in high‐risk populations: A narrative review of recent findings from clinical and preclinical studies
Abdolkarim Hosseini, Taleb Badri, Hadi Esmaeili Gouvarchin Ghaleh, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 36, Iss. 6, pp. 918-929
Open Access | Times Cited: 5
Abdolkarim Hosseini, Taleb Badri, Hadi Esmaeili Gouvarchin Ghaleh, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 36, Iss. 6, pp. 918-929
Open Access | Times Cited: 5
Development of indolealkylamine derivatives as potential multi-target agents for COVID-19 treatment
Jyoti Chauhan, Erika Cecon, Nedjma Labani, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115152-115152
Open Access | Times Cited: 2
Jyoti Chauhan, Erika Cecon, Nedjma Labani, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115152-115152
Open Access | Times Cited: 2
Clinical research and drug regulation in the challenging times of individualized therapies: A pivotal role of clinical pharmacology
Antonio Gómez‐Outes, Aránzazu Sancho‐López, Antonio J. Carcas, et al.
Pharmacological Research (2023) Vol. 199, pp. 107045-107045
Open Access | Times Cited: 2
Antonio Gómez‐Outes, Aránzazu Sancho‐López, Antonio J. Carcas, et al.
Pharmacological Research (2023) Vol. 199, pp. 107045-107045
Open Access | Times Cited: 2
Role of Melatonin in Management of COVID-19: A Systematic Review
Ghada Essam El-Din Amin, Salwa Rahman, Rehab M. Mohamed, et al.
Microbes Infection and Chemotherapy (2024) Vol. 4, pp. e1982-e1982
Open Access
Ghada Essam El-Din Amin, Salwa Rahman, Rehab M. Mohamed, et al.
Microbes Infection and Chemotherapy (2024) Vol. 4, pp. e1982-e1982
Open Access
Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19
Anabel González‐Acedo, Francisco Javier Manzano‐Moreno, Enrique García‐Recio, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3070-3070
Open Access
Anabel González‐Acedo, Francisco Javier Manzano‐Moreno, Enrique García‐Recio, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3070-3070
Open Access
The circadian rhythm of viruses and its implications on susceptibility to infection
José Ramón Blanco, Eva M. Verdugo‐Sivianes, Ana Amiama-Roig, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1109-1117
Closed Access | Times Cited: 3
José Ramón Blanco, Eva M. Verdugo‐Sivianes, Ana Amiama-Roig, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1109-1117
Closed Access | Times Cited: 3
Neglected Effective Early Therapies against COVID-19: Focus on Functional Foods and Related Active Substances. A Review
Alberto Donzelli
(2023)
Open Access | Times Cited: 1
Alberto Donzelli
(2023)
Open Access | Times Cited: 1
Melatonin’s Benefits as a Treatment for COVID-19 Pandemic and Long COVID
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
(2023), pp. 385-403
Closed Access
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
(2023), pp. 385-403
Closed Access
Scientific basis for the use of melatonin in COVID 19
J.A. Fernández-Tresguerres Hernández, Lisa Rancán, Sergio D. Paredes, et al.
ANALES RANM (2022) Vol. 139, Iss. 139(02), pp. 135-139
Open Access
J.A. Fernández-Tresguerres Hernández, Lisa Rancán, Sergio D. Paredes, et al.
ANALES RANM (2022) Vol. 139, Iss. 139(02), pp. 135-139
Open Access
